Abstract:Objectives: To study the underlying alteration in the expression of epithelial markers involved in epithelial-mesenchymal transition (EMT), and elucidate the potential mechanism(s) for T beta 4-induced EMT-like phenotypic changes in bladder cancer cells. Materials and methods: All tissue samples in this study were obtained from clinical patients of the Union Hospital of Tongji Medical College, and were confirmed by surgery and pathology. Of these, normal bladder tissues (control), primary urothelial carcinoma of different grades (Stage pTa, Stage pT3), bladder paracancerous tissues, accompanied with 2 bladder cancer cell lines (BIU-87 and T24), were divided into 6 groups. Quantitative RT-PCR, Western blotting, and immunohistochemical study of adhesion molecules T beta 4, ILK, E-cadherin, and p-catenin involved in EMT were carried out. A lentiviral gene transferring vector containing the RNA polymerase III-dependent U6 promoter to express short hairpin RNA (shRNA) directed against T beta 4 was also applied. In the present study, all agents were evaluated using commercial kits. Results: A strong correlation between the expression levels of T beta 4, ILK, E-cadherin, and (beta-catenin was found in the bladder transitional cell carcinoma (TCC) patients. In the BIU-87 and T24 bladder cancer cells overexpressing T beta 4, which were accompanied by a loss of E-cadherin as well as a cytosolic accumulation of P-catenin, up-regulation of ILK was also revealed. The inhibition of the T beta 4 expression with lentiviral shRNA vector could raise EMT-like phenotypic changes, significantly depressed motility, and subsequent invasiveness of bladder cancer cells. Conclusions: Our results imply that the T beta 4 is likely to play a crucial role in EMT progression, and that inhibition of the T beta 4 expression or interactions with other genes should be novel therapeutic targets for bladder cancers with high invasive and metastatic potential. (C) 2012 Elsevier Inc. All rights reserved.

Aberrantly Upregulated EF4 Is Crucial for The Proliferation and Migration of Bladder Urothelial Carcinoma Cells <i>via</i> Orchestration of Mitochondrial Oxidative Phosphorylation

Human Elongation Factor 4 Regulates Cancer Bioenergetics by Acting As a Mitochondrial Translation Switch

ATF4/NUPR1 Axis Promotes Cancer Cell Survival and Mediates Immunosuppression in Clear Cell Renal Cell Carcinoma

MiR-144-3p-mediated Dysregulation of EIF4G2 Contributes to the Development of Hepatocellular Carcinoma Through the ERK Pathway

Testicular Nuclear Receptor 4 Regulates Proliferation and Apoptosis of Bladder Cancer <i>via</i> Bcl-2

Tead4 As A Prognostic Marker Promotes Cell Migration And Invasion Of Urinary Bladder Cancer Via Emt

Evaluation of Thymosin Β4 in the Regulation of Epithelial-Mesenchymal Transformation in Urothelial Carcinoma.

[Expression and Function of ECRG4 in Hepatocellular Carcinoma].

Comprehensive Analysis of E47‑like Factors and Verification of ELF4 in Clear Cell Renal Cell Carcinoma.

HNF‑4α downregulation promotes tumor migration and invasion by regulating E‑cadherin in renal cell carcinoma.

Long Noncoding RNA AC114812.8 Promotes the Progression of Bladder Cancer Through Mir-371B-5p/fut4 Axis.

PDE4B Induces Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Is Transcriptionally Suppressed by CBX7

E2F4 Promotes the Proliferation of Hepatocellular Carcinoma Cells through Upregulation of CDCA3

OCT3/4 enhances tumor immune response by upregulating the TET1-dependent NRF2/MDM2 axis in bladder cancer

CAFs-derived MFAP5 Promotes Bladder Cancer Malignant Behavior Through NOTCH2/HEY1 Signaling.

E2F8 facilitates malignant phenotypes of muscle-invasive bladder cancer via increasing MCM7 expression

The oncogenic role of EIF4A3/CDC20 axis in the endometrial cancer

Utility of EFEMP1 in the Prediction of Oncologic Outcomes of Urothelial Carcinoma

Expression of MAP4K4 in Bladder Cancer and Its Biological Effect on Human Bladder Cancer T24 Cells

Data from TRAF4 Inhibits Bladder Cancer Progression by Promoting BMP/SMAD Signaling

A distinct subset of urothelial cells with enhanced EMT features promotes chemotherapy resistance and cancer recurrence by increasing COL4A1-ITGB1 mediated angiogenesis